FTC seeks more information to review Bristol-Celgene's $74 bln planned merger
March 26, 2019 at 08:29 AM EDT
The U.S. Federal Trade Commission has sought additional information and documents from Bristol-Myers Squibb Co and Celgene Corp in connection with its review of their planned merger, Bristol-Myers said on Tuesday.
